Margaret L. Rand

4.5k total citations
109 papers, 2.7k citations indexed

About

Margaret L. Rand is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Margaret L. Rand has authored 109 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 28 papers in Cardiology and Cardiovascular Medicine and 18 papers in Surgery. Recurrent topics in Margaret L. Rand's work include Platelet Disorders and Treatments (66 papers), Antiplatelet Therapy and Cardiovascular Diseases (26 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Margaret L. Rand is often cited by papers focused on Platelet Disorders and Treatments (66 papers), Antiplatelet Therapy and Cardiovascular Diseases (26 papers) and Blood Coagulation and Thrombosis Mechanisms (23 papers). Margaret L. Rand collaborates with scholars based in Canada, United States and Switzerland. Margaret L. Rand's co-authors include Marian A. Packham, Victor S. Blanchette, R L Kinlough-Rathbone, Raphael Rubin, John Freedman, Roland Leung, Sara J. Israels, Manuel Carção, Markus Schmugge and David Lillicrap and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Margaret L. Rand

106 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret L. Rand Canada 29 1.5k 567 469 297 279 109 2.7k
Jaime Pereira Chile 28 1.2k 0.8× 620 1.1× 467 1.0× 282 0.9× 291 1.0× 90 2.6k
Diego Mezzano Chile 34 1.9k 1.2× 741 1.3× 416 0.9× 492 1.7× 461 1.7× 109 3.5k
Rüdiger E. Scharf Germany 27 1.4k 1.0× 817 1.4× 485 1.0× 228 0.8× 266 1.0× 132 2.7k
M Dechavanne France 31 1.3k 0.8× 495 0.9× 529 1.1× 536 1.8× 508 1.8× 137 3.1k
Núria Sala Spain 29 1.2k 0.8× 238 0.4× 648 1.4× 616 2.1× 575 2.1× 97 2.8k
L. Mussoni Italy 31 587 0.4× 729 1.3× 709 1.5× 403 1.4× 570 2.0× 95 2.7k
MA Packham Canada 33 1.7k 1.1× 1.2k 2.1× 576 1.2× 849 2.9× 499 1.8× 96 3.6k
J. V. Lloyd Australia 29 1.1k 0.7× 441 0.8× 351 0.7× 160 0.5× 240 0.9× 98 2.1k
Yohko Kawai Japan 26 827 0.5× 949 1.7× 316 0.7× 245 0.8× 418 1.5× 67 2.4k
Takatoshi Koyama Japan 28 601 0.4× 187 0.3× 447 1.0× 105 0.4× 504 1.8× 92 2.0k

Countries citing papers authored by Margaret L. Rand

Since Specialization
Citations

This map shows the geographic impact of Margaret L. Rand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret L. Rand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret L. Rand more than expected).

Fields of papers citing papers by Margaret L. Rand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret L. Rand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret L. Rand. The network helps show where Margaret L. Rand may publish in the future.

Co-authorship network of co-authors of Margaret L. Rand

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret L. Rand. A scholar is included among the top collaborators of Margaret L. Rand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret L. Rand. Margaret L. Rand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steele, MacGregor, Jeremy Friedman, Ran D. Goldman, et al.. (2024). Constitutive hypercoagulability in pediatric sickle cell disease patients with hemoglobin SS genotype. Research and Practice in Thrombosis and Haemostasis. 8(3). 102374–102374.
2.
Schmugge, Markus, et al.. (2023). IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia. British Journal of Haematology. 201(6). 1209–1219. 5 indexed citations
3.
Rand, Margaret L., et al.. (2023). Commonly Associated Disorders with Complete Scalp Alopecia in Early Childhood. International Journal of Trichology. 15(2). 43–49.
4.
Khan, Hamzah, Muzammil H. Syed, Margaret L. Rand, et al.. (2022). Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease. Frontiers in Cardiovascular Medicine. 9. 912114–912114. 7 indexed citations
5.
Blanchette, Victor S., David Lillicrap, Shannon Jackson, et al.. (2018). A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a. Blood. 132(Supplement 1). 2480–2480. 1 indexed citations
6.
Segbefia, Catherine, Tina Biss, Dewi Clark, et al.. (2017). Severity and Features of Epistaxis in Children with a Mucocutaneous Bleeding Disorder. The Journal of Pediatrics. 193. 183–189.e2. 3 indexed citations
7.
Kuo, Kevin H.M., Margaret L. Rand, Hira Mian, et al.. (2016). EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis. PLoS ONE. 11(3). e0149830–e0149830. 2 indexed citations
8.
Israels, Sara J., Walter H.A. Kahr, Victor S. Blanchette, et al.. (2011). Platelet disorders in children: A diagnostic approach. Pediatric Blood & Cancer. 56(6). 975–983. 54 indexed citations
9.
Kroiss, Sabine, et al.. (2011). Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin. British Journal of Haematology. 156(4). 508–515. 48 indexed citations
10.
Biss, Tina, Victor S. Blanchette, Dewi Clark, et al.. (2010). Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. Journal of Thrombosis and Haemostasis. 8(5). 950–956. 99 indexed citations
11.
Gwozdz, Adam, Roland Leung, Hong Wang, et al.. (2010). Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects. Thrombosis and Haemostasis. 103(6). 1218–1227. 10 indexed citations
12.
Biss, Tina, Victor S. Blanchette, Dewi Clark, et al.. (2009). Evaluation of Bleeding Symptoms in Children with An Inherited Mucocutaneous Bleeding Disorder.. Blood. 114(22). 1292–1292. 2 indexed citations
13.
Schmugge, Markus, Shoshana Revel‐Vilk, Linda T. Hiraki, et al.. (2003). Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. The Journal of Pediatrics. 143(5). 666–669. 35 indexed citations
14.
Schmugge, Markus, Margaret L. Rand, K. W. Annie Bang, et al.. (2003). The Relationship of von Willebrand Factor Binding to Activated Platelets from Healthy Neonates and Adults. Pediatric Research. 54(4). 474–479. 22 indexed citations
15.
Revel‐Vilk, Shoshana, Markus Schmugge, Manuel Carção, et al.. (2003). Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease. Journal of Pediatric Hematology/Oncology. 25(11). 874–879. 37 indexed citations
16.
Rand, Margaret L., et al.. (2002). Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function. Journal of Laboratory and Clinical Medicine. 140(6). 391–397. 6 indexed citations
17.
Stone, David C., et al.. (2001). Blood platelet adhesion to protein studied by on-line acoustic wave sensor. The Analyst. 126(3). 342–348. 9 indexed citations
18.
Kinlough-Rathbone, R L, Dennis Perry, Margaret L. Rand, & Marian A. Packham. (1999). Effects of Cathepsin G Pretreatment of Platelets on their Subsequent Responses to Aggregating Agents. Thrombosis Research. 95(6). 315–323. 14 indexed citations
19.
Rand, Margaret L., Manuel Carção, & Victor S. Blanchette. (1998). Use of the PFA-100®in the Assessment of Primary, Platelet-Related Hemostasis in a Pediatric Setting. Seminars in Thrombosis and Hemostasis. 24(6). 523–529. 31 indexed citations
20.
Gross, Peter L., et al.. (1991). Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 11(3). 610–616. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaime Pereira Breakdown of academic impact, for papers by Diego Mezzano Breakdown of academic impact, for papers by Rüdiger E. Scharf Breakdown of academic impact, for papers by M Dechavanne Breakdown of academic impact, for papers by Núria Sala Breakdown of academic impact, for papers by L. Mussoni Breakdown of academic impact, for papers by MA Packham Breakdown of academic impact, for papers by J. V. Lloyd Breakdown of academic impact, for papers by Yohko Kawai Breakdown of academic impact, for papers by Takatoshi Koyama
Rankless by CCL
2026